Incannex Healthcare Inc（IXHL）财务数据IXHLIncannex Healthcare Inc

Evaluating the bottom line, Incannex Healthcare Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -47.80%, provide a clear picture of how effectively IXHL converts its operational activities into shareholder value.

In the context of the broader market, IXHL competes directly with industry leaders such as FLNA and IRLA. With a market capitalization of $28.09M, it holds a significant position in the sector. When comparing efficiency, IXHL's gross margin of N/A stands against FLNA's N/A and IRLA's N/A. Such benchmarking helps identify whether Incannex Healthcare Inc is trading at a premium or discount relative to its financial performance.

The company has shown a drastic decline in revenue, with total revenue of only $12,000 in Q2 2025, followed by zero revenue in subsequent quarters. Net income has been consistently negative, with the latest figure at -$2,491,000 for Q4 2026. The gross margin is currently at 0%, indicating no profitability from sales.